期刊文献+

甲状腺癌的超声诊断和淋巴结转移112例分析 被引量:1

Analysis on the Clinical Effect of Ultrasonography in 112 Thyroid Cancer Cases Complicated with Lymphatic Metastasis
下载PDF
导出
摘要 目的研究甲状腺癌的超声诊断和淋巴结转移情况。方法选取2014年5月-2016年5月期间收治的甲状腺癌淋巴结转移患者112例进行回顾性分析。对患者临床资料进行分析,对比患者资料要点。结果全部患者当中,乳头状癌患者在全部患者当中占据97.32%(n=109),乳头状微灶癌患者占据全部患者数量的44.64%(n=50)。对患者进行B超影响指标的诊断,其中的约登指数为细化钙患者占据总数的62.5%(n=70),边界模糊患者占据64.28%(n=72),并存患者为55.35%(n=62),供血增多患者为37.5%(n=43),低回声患者占据8.03%(n=9)。患者中有31例有淋巴结转移(27.6%),平均淋巴结数为(2.41±0.32)枚。结论当前乳头癌患者在甲状腺癌当中占据着绝大多数,在甲状腺患者进行治疗之前,需对其作出超声波检查,促使患者诊断价值得以提升。与此同时,甲状腺癌当中,乳头状微灶癌VI区域淋巴转移有可能会出现比较高阳性,这就需要在临床上,针对需要的患者开展淋巴结清扫手术治疗。 Objective To analyze the clinical effect of ultrasonography in thyroid cancer patients complicated with lymphatic metastasis. Methods Clinical data about 112 thyroid cancer patients complicated with lymphatic metastasis treated from May 2014 to May 2016 in our hospital was reviewed. Results 97.32%(n =109) of the patients had the papillary carcinoma. The rate of papillary micro-carcinoma was 44.64%(n =50). According to the B ultrasound results,the rate of refined calcification,fuzzy boundary,complex condition of refined calcification and fuzzy boundary,increasing blood supply and hypoecho was 62.5%(n=70),64.28%(n=72),55.35%(n=62),37.5%(n=43) and 8.03%(n=9). lymph node metastasis was found in 31 patient(27.6%)and the average number of lymph nodes was(2.41 + 0.32). Conclusion Most of the papillary carcinoma patients have the thyroid cancer. Before treatment,the ultrasonography is essential. For papillary micro-carcinoma patients complicated with VI regional lymphatic metastasis,the positive rate is high. In clinical practice,the lymph node dissection is required.
作者 林琳
出处 《口岸卫生控制》 2017年第6期27-29,共3页 Port Health Control
关键词 甲状腺 超声诊断 淋巴结转移 Thyroid Ultrasonography Lymphatic metastasis
  • 相关文献

参考文献6

二级参考文献79

  • 1詹维伟,徐上妍.甲状腺结节超声检查新进展[J].中华医学超声杂志(电子版),2013,10(2):88-93. 被引量:73
  • 2刘跃武,李小毅,高维生.美、英、日三国分化型甲状腺癌手术指南的比较[J].外科理论与实践,2005,10(6):567-568. 被引量:29
  • 3柳文保,薛新波,王从俊,曹胜华.分化型甲状腺癌复发因素分析[J].临床外科杂志,2006,14(3):171-172. 被引量:2
  • 4Lim YC, Lee JS, Koo BS, et al. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma [Jl. Laryngoscope,2006, 116(2):268-272.
  • 5Farrag T, Lin F, Brownlee N, et al Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-eonfirmed metastases in other levels [J]. World J Surg, 2009, 33(8): 1680-1683.
  • 6Caron NR, Tan YY, Ogilvie JB, et al. Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary? [J] . World J Surg, 2006, 30(5): 833-840.
  • 7Ito Y, Miyauchi A. Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma [J]. World J Surg, 2008, 32(5):729-739.
  • 8Caron NR, Clark OH. Papillary thyroid cancer: surgical management of lymph node metastases [J]. Curr Treat 'Options Oncol, 2005, 6(4):311-322.
  • 9Lee J, Sung TY, Nam KH, et al. Is level IIb lymph node dissection always necessary in Nlb papillary thyroid carcinoma patients? [J]. World J Surg, 2008, 32(5):716-721.
  • 10Mazzaferri EL,Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin[J]. Endocr Relat Cancer, 2002,9(4)227-247.

共引文献117

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部